Description
Product Overview
CJC/IPA is a lyophilized dual-peptide preparation formulated from two synthetic amino acid sequences designed for in vitro research applications. This combination is intended for laboratory analysis of peptide interaction, receptor signaling behavior, and sequence stability within controlled biochemical environments. Each peptide serves as a model analog for studying growth-related biochemical pathways and secretion dynamics.
Chemical Characteristics
Both components of CJC/IPA are produced with high purity and molecular precision. The first peptide acts as a structural analog of a growth hormone–releasing sequence (GHRH-type), while the second represents a receptor-binding fragment similar to GHRP-type sequences. Together, these peptides allow for detailed examination of receptor affinity, signal frequency modulation, and synergistic peptide responses during laboratory assays.
Specifications
- Unit Size: 10 mg + 5 mg per vial
- Form: Lyophilized powder
- Storage: Store in a cool, dry environment away from direct light and moisture
Research Context
CJC/IPA is intended exclusively for qualified laboratory research use. It may be utilized in receptor pathway mapping, secretion modeling, and comparative studies of peptide sequence stability under various controlled experimental conditions.
For Research Use Only (RUO)
This product is provided strictly for scientific and laboratory research. It is not for human or veterinary consumption, and must not be used in medical, diagnostic, or therapeutic applications.
Disclaimer
CJC/IPA has not been reviewed or approved by the FDA or any other regulatory authority. It is supplied solely for in vitro research and educational purposes. All descriptive content is for scientific reference only. By purchasing this compound, the buyer confirms they are a qualified researcher operating within all applicable legal and safety standards.
